PET-CT

PET-CT combines positron emission tomography (PET) detectors and computed tomography (CT) into one imaging system. 

GE Healthcare Q.Clear Technology PET/CT Systems Nuclear Imaging
Feature | April 08, 2014

April 8, 2014 — GE Healthcare received U.S. Food and Drug Administration (FDA) 510(k) clearance of its Q.Clear...

Whole Body PET

Coronary CTA on the Somatom Force produces high-resolution stent imaging with a 0.18 second scan at 70 kV exposing the patient to just 0.43 mSv. The patient's heart rate varied between 58 to 70 bmp during the exam. Color image shows two long stents. The curved MPR image in grayscale shows the details in the LAD stent. Image provided by Siemens Healthcare, copyright Institut fur Klinische Radiologie und Nuklearmedicin, Universitatsmedizin Mannheim Medizinische Fakultat Mannheim der Univesitat Heidelberg

Feature | February 03, 2014 | Greg Freiherr

What was once diagnostic imaging is on track to becoming much more. Radiology is on the verge of a new era in which...

philips vereos pet/ct systems rsna 2013 molecular nuclear imaging
Technology | December 13, 2013

December 13, 2013 — Philips unveiled the Vereos PET/CT fully digital p...

News | October 21, 2013
October 21, 2013 — Jefferson Medical College researchers have developed a hologram-like display of a patient’s organs...
Feature | October 09, 2013

October 9, 2013 — Each year, 13 percent of all newly diagnosed...

Siemens, Siemens logo, Siemens Healthcare
News | October 01, 2013

October 1, 2013 — Based on its recent analysis of the molecular imaging market, Frost & Sullivan recognizes...

News | August 07, 2013

August 7, 2013 — A more precise method for determining bone marrow involvement in patients with diffuse large B-cell...

GE Healthcare Recalls Many of its Nuclear Imaging Systems
Feature | July 29, 2013

July 29, 2013 — GE Healthcare has initiated a Class I recall of most of its SPECT nuclear imaging systems and called...

PET vs. SPECT, nuclear imaging advances with BFPET

BFPET demonstrates higher resolution in the evaluation of myocardial perfusion in this series of images contrasting the results of a PET scan done with FluoroPharma's fluorine-18 based agent and a SPECT study done with sestamibi. Images were captured during an investigator-initiated study of BFPET conducted at 301 Hospital in Beijing, China.

Feature | Nuclear Imaging | July 23, 2013 | Dave Fornell

Just when positron emission tomography (PET) appears to be eclipsing single photon emission computed tomography (...

News | July 08, 2013

The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is disappointed in the draft Medicare decision from...

Technology | June 11, 2013

June 11, 2013 — Siemens Healthcare has introduced Biograph mCT Flow, a...

Personalized Medicine Gets Up to Bat

Molecular imaging with PET/CT is leading off a new era of personalized medicine (photo courtesy of GE Healthcare).

Feature | June 11, 2013 | Greg Freiherr

In an increasingly impersonal world, where Facebook counts the number of friends we have and texting takes the place...

Feature | June 11, 2013

June 10, 2013 – Just a few years ago, integrated positron emission tomography and magnetic resonance (PET/MR)...

News | May 02, 2013

May 2, 2013 — Inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis, may be detected and...

Woe is PET/MR

PET/MR: better together or apart? Image courtesy of Siemens, provided by University of Geneva

Blog | March 13, 2013

What a difference a few decades makes. In the early-1980s radiologists couldn’t wait to get their hands on an MR...

Bayer Enters Agreement to Expand Markets for Medrad Intego PET Infusion System
News | March 05, 2013

March 5, 2013 - Bayer Healthcare is expanding its global distribution network for the Medrad Intego positron...

 Breast Cancer Ribbon_iStock
Feature | January 04, 2013

Jan. 2, 2013 -– New research published in the January issue of The Journal of Nuclear Medicine shows that 18F-...

PET/CT routinely plays an essential role in staging and monitoring a wide range of cancers, including lymphoma and the lung. But it has specific and significant limitations.

PET/CT routinely plays an essential role in staging and monitoring a wide range of cancers, including lymphoma and the lung. But it has specific and significant limitations.

Blog | November 20, 2012

In a skeptical world, old maxims fall hard. Photojournalists can attest to that. Seeing today is anything but...

Hybrid Imaging: The Best of Both Worlds

This SPECT/CT study clearly shows ischemia in the heart.

Feature | November 20, 2012 | Lalitha Ramanna, M.D., FACNM

The introduction of hybrid technology — positron emission tomography/computed tomography (PET/CT) and single-photon...